Morefield v. Bailey

959 F. Supp. 2d 887, 2013 WL 4010295, 2013 U.S. Dist. LEXIS 111362
CourtDistrict Court, E.D. Virginia
DecidedAugust 6, 2013
DocketCase No. 1:12-cv-1468 (GBL/TCB)
StatusPublished
Cited by12 cases

This text of 959 F. Supp. 2d 887 (Morefield v. Bailey) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Morefield v. Bailey, 959 F. Supp. 2d 887, 2013 WL 4010295, 2013 U.S. Dist. LEXIS 111362 (E.D. Va. 2013).

Opinion

MEMORANDUM OPINION AND ORDER

GERALD BRUCE LEE, District Judge.

THIS MATTER is before the Court on Defendants’ Motion to Dismiss for failure to comply with Rule 23.1’s shareholder derivative demand requirement and Motion to Dismiss for failure to state a claim. (Docs. 40, 43.) This case concerns the activities of a Nevada corporation’s board of directors (“the Board”) in connection with their management decisions and public statements related to the company’s major contract with the United Kingdom’s healthcare system. Plaintiff Shirley More-field brings this action, alleging one count of breach of fiduciary duty on the grounds of deception and mismanagement by the board of directors. The present Motions present two issues before the Court.

The first issue is whether Plaintiff sufficiently pleaded with particularity that the Board wrongfully refused her demand to sue itself on behalf of the corporation. The Court holds that Plaintiff fails to plead wrongful refusal with particularity as re[893]*893quired by Federal Rule of Civil Procedure 23.1. The Board’s refusal of Plaintiffs demand to sue certain corporate officers indicated various reasons considered by the Board for its refusal to take her suggested course of action. In light of the refusal letter and the facts available to the Board as a result of an internal investigation, a governmental investigation, and federal securities litigation, Plaintiff fails to allege facts that would sufficiently rebut the presumption that the Board’s actions are protected by the business judgment rule. Accordingly, the Amended Complaint is subject to dismissal for this reason.

The second issue is whether, assuming the demand requirement was met, Plaintiff sufficiently states a claim for breach of fiduciary duty where she alleges that individuals on the board of directors failed to conduct proper oversight, received reports indicating a dire financial outlook, and disseminated incorrect information regarding the corporation’s financial situation. The Court holds that Plaintiff fails to state a claim for breach of fiduciary duty. The Complaint lacks facts sufficiently demonstrating that the named defendants engaged in intentional misconduct or consciously failed to manage or oversee the corporation’s internal monitoring systems. Accordingly, Defendants are entitled to dismissal for this reason as well.

I. BACKGROUND

Plaintiff Shirley Morefield brings this breach of fiduciary duty action derivatively and on behalf of Nominal Defendant Computer Sciences Corporation (“CSC”) against current and former CSC directors and officers. (Am. Compl. ¶ 1, Doc. 26.) Plaintiff brings this suit as a CSC stockholder. (Id. ¶ 14.) CSC is a Nevada corporation that provides information technology and business process outsourcing, consulting and systems integration services, and other professional services. (Id. ¶¶ 26, 35.) The named defendants are Irving W. Bailey, David J. Barram, Stephen L. Baum, Rodney F. Chase, Judith R. Haberkorn, Michael W. Laphen, Michael J. Mancuso, F. Warren McFarlan, Chong Sup Park, and Thomas H. Patrick (“Individual Defendants”), and Computer Sciences Corporation as a Nominal Defendant. (See id. at 1.)

Plaintiffs breach of fiduciary duty claim arises from a series of incidents occurring primarily between 2008 and 2012. During this time, CSC held a $5.4 billion contract with the United Kingdom’s National Health Sendee (“NHS Contract”) “to create a fully-integrated patient and medical records Information Technology system throughout the UK.” (Id. ¶¶2, 36, 56.) Plaintiff alleges that “the Individual Defendants were responsible for disseminating numerous false and misleading statements concerning the Company’s internal controls and profitability during the Company’s fiscal years 2009-11.” (Id. ¶42.) Many of these statements allegedly concerned the profitability of the NHS Contract, CSC’s ability to fulfill the terms of the NHS Contract, and the adequacy and effectiveness of CSC’s internal controls. (Id.) Plaintiff alleges that the Individual Defendants “knowingly caused or allowed the Company to issue” such misstatements “in press releases, Form 10-Q filings, Form 10-K filings, and conference calls from August 5, 2008 through August 11, 2010.” (Id. ¶ 43.) The Complaint summarizes a non-exhaustive list of dates and forms containing misstatements but does not specify the contents of or attach a specific date to any particular misstatement. (See id.)

Plaintiff presents a series of allegations concerning public statements and events occurring no earlier than November 2010, whereby CSC made significant adjustments to financial outlooks, including adjustments in light of accounting errors and [894]*894irregularities, reflecting the fact that CSC’s “internal controls and procedures were not effective as of October 1, 2010.” (Id. ¶¶ 44-49.) During this time the Securities Exchange Commission (“SEC”) initiated a formal civil investigation into CSC’s accounting practices. (Id. ¶ 47.) No later than February 2011, CSC initiated reviews and investigations of its internal controls. (Id. ¶ 49.) During 2011, CSC continued to release public documents reflecting its discovery of internal accounting errors while carefully refraining from commenting on the details of such errors in light of the SEC investigation. (Id. ¶¶ 50-55.) CSC made further adjustments to financial projections, particularly those concerning the NHS Contract, in February and May of 2011. (Id. ¶¶ 56-57.) Company-wide revenue expectations declined by approximately $2 billion with respect to new business, while the value of the NHS Contract decreased in value by nearly $1 billion. (See id.)

Plaintiff further describes a series of internal communications allegedly sent in 2008 to Defendant Laphen and other individuals concerning the accounting inefficiencies in CSC’s Nordic operations. (Id. ¶¶ 61-70.) Some of these letters stated the belief of certain individuals that the internal audit practice in the Nordic region posed a “significant risk to [] CSC” and that the chief audit executive “seriously compromised the integrity of the practice as well as the financials of this firm.” (Id. ¶¶ 66-67.) Plaintiff also presents allegations concerning an internal review team and its belief that CSC would be unable to meet deadlines imposed by the NHS Contract. (Id. ¶ 72.) This review team — the DA Red Team — allegedly spent two weeks assessing projections related to the NHS Contract and concluded that, due to the project being behind schedule, CSC “could not deliver the solution set” required by the NHS Contract. (Id. ¶¶ 72-80.) This report was allegedly presented to the Board of Directors in May 2008. (Id. ¶ 80.) A second review team, commissioned in September 2008, concluded that some aspects of CSC’s project made solid progress but ultimate delivery on schedule would be highly unlikely and test results were “abysmal.” (Id. ¶¶ 81-83.)

Plaintiff alleges that CSC ultimately failed to timely deliver the programs required by the NHS Contract, causing a decline in the value of the NHS Contract. (Id. ¶ 86.) The withdrawal of the Penine Trust Foundation from the NHS program allegedly caused a cancellation of at least $175 million in revenue. (Id.) As of June 15, 2011, the value of the NHS Contract allegedly fell to $3.4 billion from $5.4 billion. (Id.)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ali v. Moslov
E.D. Virginia, 2025
Chacko v. Preston
E.D. Virginia, 2024
Rob Star v. TI Oldfield Development, LLC
962 F.3d 117 (Fourth Circuit, 2020)
King v. Plank
D. Maryland, 2020
Islet Scis., Inc. v. Brighthaven Ventures, LLC
2017 NCBC 4 (North Carolina Business Court, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
959 F. Supp. 2d 887, 2013 WL 4010295, 2013 U.S. Dist. LEXIS 111362, Counsel Stack Legal Research, https://law.counselstack.com/opinion/morefield-v-bailey-vaed-2013.